JP, A., KB, G., R, P., CT, K., SA, K., M, K., . . . SF, T. (2024). Clinical features, functional consequences, and rescue pharmacology of missense GRID1 and GRID2 human variants. Human molecular genetics, 33(4), 355. https://doi.org/10.1093/hmg/ddad188
Chicago Style (17th ed.) CitationJP, Allen, et al. "Clinical Features, Functional Consequences, and Rescue Pharmacology of Missense GRID1 and GRID2 Human Variants." Human Molecular Genetics 33, no. 4 (2024): 355. https://doi.org/10.1093/hmg/ddad188.
MLA (9th ed.) CitationJP, Allen, et al. "Clinical Features, Functional Consequences, and Rescue Pharmacology of Missense GRID1 and GRID2 Human Variants." Human Molecular Genetics, vol. 33, no. 4, 2024, p. 355, https://doi.org/10.1093/hmg/ddad188.